000 | 01342 a2200397 4500 | ||
---|---|---|---|
005 | 20250513165308.0 | ||
264 | 0 | _c19990318 | |
008 | 199903s 0 0 dut d | ||
022 | _a0028-2162 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _ade Jong-van den Berg, L T | |
245 | 0 | 0 |
_a[Thalidomide once more in the spotlight]. _h[electronic resource] |
260 |
_bNederlands tijdschrift voor geneeskunde _cNov 1998 |
||
300 |
_a2509-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 |
_aBone Marrow Transplantation _xadverse effects |
650 | 0 | 4 | _aContraindications |
650 | 0 | 4 |
_aDrug Approval _xlegislation & jurisprudence |
650 | 0 | 4 |
_aDrug and Narcotic Control _xlegislation & jurisprudence |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft vs Host Disease _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aNetherlands |
650 | 0 | 4 | _aPregnancy |
650 | 0 | 4 | _aPrenatal Exposure Delayed Effects |
650 | 0 | 4 |
_aStomatitis, Aphthous _xdrug therapy |
650 | 0 | 4 |
_aTeratogens _xpharmacology |
650 | 0 | 4 |
_aThalidomide _xpharmacology |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xantagonists & inhibitors |
650 | 0 | 4 | _aUnited States |
700 | 1 | _aRutgers, J | |
700 | 1 | _aCornel, M C | |
773 | 0 |
_tNederlands tijdschrift voor geneeskunde _gvol. 142 _gno. 46 _gp. 2509-12 |
|
999 |
_c9989616 _d9989616 |